Godrej Agrovet Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
GODREJAGRO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts more than Nifty Microcap 250 and 1.8 pts more than its Food Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Godrej Agrovet reported strong Q1 FY26 results with standalone revenue from operations up ~15% YoY to Rs 2,006.56 crore and standalone PAT up ~24% to Rs 168.89 crore. Consolidated revenue rose ~11% to Rs 2,614.29 crore with consolidated PAT at Rs 148.83 crore (~13% YoY growth). Operating margins expanded sharply — standalone operating margin moved from 8.42% to 12.90% YoY, driven by strong performances in Vegetable Oil and Crop Protection segments. The company acquired the balance 36.79% stake in Creamline Dairy for Rs 708.58 crore, raising its holding to 99.32% (later 99.67%). It also participated in Astec LifeSciences' Rs 249.35 crore rights issue, raising its stake there to 67.03%. Statutory auditors BSR & Co. LLP issued an unmodified limited review opinion on both standalone and consolidated results.
Positive quarterly performance with sharp margin expansion signals operational leverage, especially in the Vegetable Oil and Crop Protection businesses. However, the Rs 708+ crore Creamline Dairy acquisition and rights issue participation increase capital deployment and consolidation risks; shareholders should watch integration and the minor reduction in non-controlling interest going forward.